Zobrazeno 1 - 10
of 166
pro vyhledávání: '"vaxzevria"'
Autor:
Charlotte Davis, Dave Singh, Katie Anderson, Antonella Vardeu, Jakub Kopycinski, Alice Bridges-Webb, Alice Trickett, Susanne O’Brien, Matthew Downs, Randip Kaur, Radka Kolenovska, Louise Bussey, Kathryn Rutkowski, Sarah Sebastian, Tamsin Cargill, Eleanor Barnes, Thomas G. Evans, Paola Cicconi
Publikováno v:
Vaccines, Vol 12, Iss 6, p 644 (2024)
There are varying data concerning the effect of prior anti-vector immunity on the T-cell response induced by immunisation with an identical vectored vaccine containing a heterologous antigen insert. To determine whether prior exposure to ChAdOx1-SARS
Externí odkaz:
https://doaj.org/article/face05f3e51d423d870639594d13c324
Autor:
Luca Roncati, Antonio Manenti
Publikováno v:
Brain Hemorrhages, Vol 4, Iss 1, Pp 27-29 (2023)
Pituitary apoplexy (PA) may complicate the course of coronavirus disease 2019 (COVID-19), posing a potential threat to life. Among vaccines designed to prevent COVID-19, there are those adenoviral vector-based, such as Vaxzevria® (formerly COVID-19
Externí odkaz:
https://doaj.org/article/f9dff0e3446840c0b1810406d2bff22e
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: The COVID-19 pandemic has resulted in more than 6.5 million deaths worldwide yet. Vaccination against the SARS-CoV-2 virus is a reliable way out of the pandemic, however, vaccination rate reaches only 58% in the Slovak Republic. Concern
Externí odkaz:
https://doaj.org/article/750077391b604cfb995bda6119bf361b
Autor:
George N. Konstantinou
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
Cases that experienced COVID-19 postvaccination-related thrombosis have been reported after the first dose of ChAdOx1 nCov-19 (Vaxzevria, AstraZeneca) or Ad26.COV2.S (Johnson & Johnson/Janssen) vaccine. These rare thrombotic events were observed with
Externí odkaz:
https://doaj.org/article/26ce8f3c43a54459bd363ebb50689eb3
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1625 (2023)
Background: The emergence of the SARS-CoV-2 (COVID-19) pandemic has accelerated work on the creation of effective vaccines, both in terms of previously known vector vaccines and new-generation (mRNA) vaccines. The scientific research on vaccination a
Externí odkaz:
https://doaj.org/article/26d1723a0057470ca1fcc5e25f560238
Autor:
Thiago Cerqueira-Silva, Vinicius de Araújo Oliveira, Viviane S. Boaventura, Julia M. Pescarini, Juracy Bertoldo Júnior, Tales Mota Machado, Renzo Flores-Ortiz, Gerson O. Penna, Maria Yury Ichihara, Jacson Venâncio de Barros, Mauricio L. Barreto, Guilherme Loureiro Werneck, Manoel Barral-Netto
Publikováno v:
The Lancet Regional Health. Americas, Vol 6, Iss , Pp 100154- (2022)
Summary: Background: Aging influences COVID-19 severity and response to vaccination, but previous vaccine effectiveness (VE) analyzes lack the power to evaluate its role in subgroups within the elderly age group. Here we analyzed the impact of age on
Externí odkaz:
https://doaj.org/article/d81b9bc545004ea7b3ab947da96d57fb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 24, Iss , Pp 101207- (2021)
Purpose: To describe a case of acute macular neuroretinopathy (AMN) in a 23-year-old Caucasian female after a COVID-19 vaccination (Vaxzevira). Observations: Our patient perceived visual symptoms in both eyes one day after COVID-19 vaccination. Hypor
Externí odkaz:
https://doaj.org/article/f5382a535b194eb99d57d5bbe71b31a0
Publikováno v:
Dermatology Reports (2021)
A 66-year-old white female presented with a generalized, erythematous and itchy eruption for 3 days after. She reported having fever on the first day of eruption, complaints of asthenia, and anorexia with no other systemic symptoms. She received her
Externí odkaz:
https://doaj.org/article/c21bf13c87f64eb6a4c57e788fc32913
Autor:
Roberto Venuto, Ioselita Giunta, Mario Vaccaro, Vincenza La Fauci, Concetta Ceccio, Francesco Fedele, Antonino Privitera, Federica Denaro, Giuseppe Pantò, Rosaria Cortese, Giovanna Visalli, Smeralda D’Amato, Andrea Squeri, Raffaele Squeri, Cristina Genovese
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1803 (2022)
On 11 June 2021, the Italian Ministry of Health authorized the heterologous vaccination schedule. The goals of our retrospective study were to (a) evaluate the undesirable effects after the administration of Vaxzevria and Comirnaty vaccines; (b) eval
Externí odkaz:
https://doaj.org/article/66d7d0d004974dfda1df4eda334fcb4f